"In both age groups, the last dispensed prescription in 2023 was most commonly for injectable semaglutide [Ozempic] for Type 2 diabetes," Lee's group noted
Lilly guided to $80 billion to $83 billion in 2026 revenue after a 2025 driven by Mounjaro and Zepbound, and it got a major new catalyst when the FDA approved Foundayo, the orforglipron obesity pill, on April 1, 2026
The most common drug tests check for substances like opioids, marijuana, amphetamines, cocaine, and alcohol
NF1 mutation is associated with worse survival than sporadic MPNST [24,123,127]
Understanding BPC-157 and Sermorelin: Key Players in Regenerative Wellness BPC-157 is a peptide derived from a protein naturally found in the stomach
Sterile techniques and certified products reduce these risks significantly